Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging

Neurology

Volumn 47, Issue 3, 1996, Pages 696-704

  Tedeschi, G ^a,c   Bertolino, A ^a,c   Lundbom, N ^b,c   Bonavita, S ^a,c   Patronas, N J ^b,c   Duyn, J H ^b,c   Verhagen Metman, L ^b,c   Chase, T N ^a,c   Di Chiro, G ^a,c  

^a Experimental Therapeutics Branch   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; LACTIC ACID; N ACETYLASPARTIC ACID; PHOSPHOLIPID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; INSULA; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; THALAMUS; WHITE MATTER;

EID: 0029834577     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.3.696     Document Type: Article

References (45)

1. Terry RD. Neuropathological changes in Alzheimer disease. Prog Brain Res 1994;101:383-390.
2. Nitsch R, Pittas AG, Blusztain JK, et al. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Ann NY Acad Sei 1991;640:110-113.
3. Nitsch R, Blusztain JK, Pittas AG, et al. Evidence for a membrane defect in Alzheimer's disease brain. Proc Natl Acad Sei USA 1992;89:1671-1675.
4. Pettegrew JW, Moossy J, Withers G, McKeag D, Panchalingam K. 3 IP nuclear magnetic resonance study of the brain in Alzheimer's .disease. J Neuropathol Exp Neurol 1988; 47:235-248.
5. Prichard JW, Brass LM. New anatomical and functional imaging methods. Ann Neurol 1992;32:395-400.
6. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? [editorial]. J Neurol 1994;241:354-371.
7. Jackson EF. In vivo magnetic resonance spectroscopy in humans: a brief review. Am J Physiologic Imag 1992;7:146-154.
8. Gill SS, Small RK, Thomas DG, et al. Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2:196-200.
9. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31.
10. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
11. Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992;24:123-136.
12. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504.
13. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131-134.
14. Moffett JR, Namboodiri MA, Neale JH. Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and Nacetylaspartate immunoreactivities in rat brain. J Histochem Cytochem 1993;41:559-570.
15. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetylaspartate, creatine and choline. NMR Biomed 1991;4:47-52.
16. Barker PB, Breiter SN, Soher BJ, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994;32:157-163.
17. Prichard J. What the clinician can learn from MRS lactate measurement. NMR Biomed 1991;4:99-102.
18. Kwo-On-Yuen PF, Newmark RD, Budinger TF, Kaye JA, Ball MJ, Jagust WJ. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Res 1994;667:167-174.
19. Mohanakrishnan P, Fowler AH, Vonsattel JP, et al. An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains. Exp Brain Res 1995;102: 503-510.
20. Hunk WE, Panchalingam K, Moossy J, McClure RJ, Pettegrew JW. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology 1992;42:1578-1585.
21. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995;195:65-72.
22. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994;32:110-115.
23. Christiansen P, Schlosser A, Henriksen O. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995;13:457-462.
24. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437.
25. Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994;36:40-47.
26. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CTW. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-282.
27. Barker PB, Gillard JH, van Zijl PCM, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192:723-732.
28. Bizzi A, Movsas B, Tedeschi G, et al. Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-l MR spectroscopic imaging. Radiology 1995; 194:271-276.
29. Tedeschi G, Schiffmann R, Shih H H-L, et al. Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse white matter hypomyelination. Neurology 1995;45:1526-1532.
30. Kruse B, Barker PB, van Zijl PCM, et al. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994;36:595-608.
31. Tedeschi G, Bertolino A, Massaquoi SG, et al. Proton magnetic resonance spectroscopic imaging in cerebellar degeneration. Ann Neurol 1996;39:71-78.
32. Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995;195:58-64.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
34. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. J Psychiatr Res 1975;12:189-198.
35. Jagust WJ. Functional imaging in dementia: an overview. J Clin Psychiatry 1994;55(11, suppl):5-ll.
36. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sei USA 1985;82:4531-4534.
37. .Rogers J, Morrison JH. Quantitative morphology and regional laminar distributions of senile plaques in Alzheimer's disease. J Neurosci 1985;5:2801-2808.
38. Lewis DA, Campbell MJ, Terry RD, Morrison JH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987;7:1799-1808.
39. MacKay S, Ezekiel F, Di Scalfani V, et al. Alzheimer disease and subcortical ischémie vascular dementia: evaluation by combining MR imaging segmentation and H-l MR spectroscopic imaging. Radiology 1996;198:537-545.
40. Kamada K, Houkin K, Hida K, et al. Localized proton spectroscopy of focal brain pathology in humans: significant effects of edema on spin-spin relaxation time. Magn Reson Med 1994; 31:537-540.
41. Englund E, Brun A, Ailing C. White matter changes in dementia of Alzheimer's type: biochemical and neuropathological correlates. Brain 1988;111:1425-1439.
42. Suzuki K, Katzman R, Korey SR. Chemical studies on Alzheimer's disease. J Neuropathol Exp Neurol 1965;24:211-224.
43. Chia LS, Thompson JE, Moscarello MA. X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease. Biochim Biophys Acta 1984;775:308-312.
44. Constans JM, Meyerhoff DJ, Gerson J, et al. H-l MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischémie vascular dementia. Radiology 1995;197:517-523.
45. Englund E, Brun A. White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology 1990;16:433-439.